{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:53:52Z","timestamp":1791093232398,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s11886-006-0022-1","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T10:34:01Z","timestamp":1180694041000},"page":"119-122","source":"Crossref","is-referenced-by-count":28,"title":["Advances in pharmacologic agents in imaging: New A2A receptor agonists"],"prefix":"10.1007","volume":"8","author":[{"given":"Manuel D.","family":"Cerqueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0735-1097(94)90424-3","volume":"23","author":"MD Cerqueira","year":"1994","unstructured":"Cerqueira MD, Verani MS, Schwaiger M, et al.: Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994, 23:384\u2013389.","journal-title":"J Am Coll Cardiol"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.CIR.81.4.1205","volume":"81","author":"A Ranhosky","year":"1990","unstructured":"Ranhosky A, Kempthorne-Rawson J: The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 1990, 81:1205\u20131209.","journal-title":"Circulation"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1067\/mnc.2003.5","volume":"10","author":"RC Hendel","year":"2003","unstructured":"Hendel RC, Jamil T, Glover DK: Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 2003, 10:197\u2013204.","journal-title":"J Nucl Cardiol"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02940016","volume":"1","author":"AS Iskandrian","year":"1994","unstructured":"Iskandrian AS, Verani MS, Heo J: Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1994, 1:94\u2013111.","journal-title":"J Nucl Cardiol"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0001-2998(99)80018-X","volume":"29","author":"MI Travain","year":"1999","unstructured":"Travain MI, Wexler JP: Pharmacological stress testing. Semin Nucl Med 1999, 29:298\u2013318.","journal-title":"Semin Nucl Med"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"33D","DOI":"10.1016\/j.amjcard.2004.04.017","volume":"94","author":"MD Cerqueira","year":"2004","unstructured":"Cerqueira MD: The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol 2004, 94:33D-40D; discussion 40D\u201342D.","journal-title":"Am J Cardiol"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.CIR.98.7.711","volume":"98","author":"JC Shryock","year":"1998","unstructured":"Shryock JC, Snowdy S, Baraldi PG, et al.: A2A-adenosine receptor reserve for coronary vasodilation. Circulation 1998, 98:711\u2013718.","journal-title":"Circulation"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-200301000-00017","volume":"41","author":"JN Trochu","year":"2003","unstructured":"Trochu JN, Zhao G, Post H, et al.: Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 2003, 41:132\u2013139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(24)29370-8","volume":"298","author":"Z Gao","year":"2001","unstructured":"Gao Z, Li Z, Baker SP, et al.: Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001, 298:209\u2013218.","journal-title":"J Pharmacol Exp Ther"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.103.053306","volume":"307","author":"G Zhao","year":"2003","unstructured":"Zhao G, Linke A, Xu X, et al.: Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 2003, 307:182\u2013189.","journal-title":"J Pharmacol Exp Ther"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.CIR.94.7.1726","volume":"94","author":"DK Glover","year":"1996","unstructured":"Glover DK, Ruiz M, Yang JY, et al.: Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. Circulation 1996, 94:1726\u20131732.","journal-title":"Circulation"},{"issue":"Suppl A","key":"22_CR12","first-page":"299A","volume":"37","author":"M Kern","year":"2001","unstructured":"Kern M, Hodgson J, Rossen J, et al.: Hyperemic coronary blood flow induced by a selective adenosine A2A receptor stimulation: first report in patients of a well-tolerated novel agent for stress imaging. Abstract. J Am Coll Cardiol 2001, 37(Suppl A):299A.","journal-title":"J Am Coll Cardiol"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.0000114523.03312.7D","volume":"109","author":"JE Udelson","year":"2004","unstructured":"Udelson JE, Heller GV, Wackers FJ, et al.: Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004, 109:457\u2013464. First and largest clinical trial looking at safety and efficacy of A2A-selective agents.","journal-title":"Circulation"},{"key":"22_CR14","first-page":"II","volume":"106","author":"R Kerensky","year":"2002","unstructured":"Kerensky R, von Mering G, Kent K, et al.: Dose dependent increase in human coronary blood flow velocity following an IV bolus of CVT-3146, a novel A2A adenosine receptor agonist: a potential agent for the use in pharmacological stress testing for myocardial perfusion imaging [abstract]. Circulation 2002, 106:II-618.","journal-title":"Circulation"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","volume":"46","author":"RC Hendel","year":"2005","unstructured":"Hendel RC, Bateman TM, Cerqueira MD, et al.: Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005, 46:2069\u20132075. First trial on A2A-selective agents given as a rapid bolus at a fixed dose. Showed preliminary safety and efficacy in a small trial.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-006-0022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-006-0022-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-006-0022-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T21:10:00Z","timestamp":1737061800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-006-0022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11886-006-0022-1","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}